Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment (2004)
- Authors:
- USP affiliated authors: MARANHAO, RAUL CAVALCANTE - FCF ; RAMIRES, JOSE ANTONIO FRANCHINI - FM
- Unidades: FCF; FM
- DOI: 10.1016/j.jacc.2003.11.065
- Subjects: DOENÇAS CARDIOVASCULARES; LIPOPROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of the American College of Cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 43, n. 12, p. 2225-2232, 2004
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SPÓSITO, Andrei Carvalho et al. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, v. 43, n. 12, p. 2225-2232, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2003.11.065. Acesso em: 24 abr. 2024. -
APA
Spósito, A. C., Lemos, P. A., Santos, R. D., Hueb, W., Vinagre, C. G. C. de M., Quintella, E., et al. (2004). Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment. Journal of the American College of Cardiology, 43( 12), 2225-2232. doi:10.1016/j.jacc.2003.11.065 -
NLM
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065 -
Vancouver
Spósito AC, Lemos PA, Santos RD, Hueb W, Vinagre CGC de M, Quintella E, Carneiro O, Chapman MJ, Ramires JAF, Maranhão RC. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment [Internet]. Journal of the American College of Cardiology. 2004 ; 43( 12): 2225-2232.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.jacc.2003.11.065 - Remocao plasmatica de microemulsoes composta de colesterol e fosfolipidio em individuos normais e com doencas cardiovasculares
- Efeito da terapêutica de reposição hormonal sobre o perfil lipídico e a remoção de quilomicrons em mulheres idosas
- Efeito de fibrato na cinética de quilomícrons em pacientes com Doença Arterial Coronariana
- Efeito do fibrato na cinética de quilomícrons em pacientes com doença arterial coronariana
- Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease
- The Effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia
- LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease
- Effect of pravastatin on plasma removal at a chylomicron-like emulsion in men with coronary artery disease
- Levels of lipoprotein (a) in pulmonary arterial hypertension
- Impaired intravascular catabolism of chylomicron-like emulsions is a marker of clinical outcome in patients with stable angina
Informações sobre o DOI: 10.1016/j.jacc.2003.11.065 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
